316 related articles for article (PubMed ID: 16009860)
21. The incidence of fatal pulmonary embolism after primary hip and knee replacement in a consecutive series of 4253 patients.
Cusick LA; Beverland DE
J Bone Joint Surg Br; 2009 May; 91(5):645-8. PubMed ID: 19407300
[TBL] [Abstract][Full Text] [Related]
22. Antithrombotic therapy for stroke prevention among Medicare beneficiaries hospitalized in Alaska with atrial fibrillation.
Gordian ME; Mustin HD
Alaska Med; 1998; 40(4):79-84. PubMed ID: 10202404
[TBL] [Abstract][Full Text] [Related]
23. Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery.
Katz J; Feldman MA; Bass EB; Lubomski LH; Tielsch JM; Petty BG; Fleisher LA; Schein OD;
Ophthalmology; 2003 Sep; 110(9):1784-8. PubMed ID: 13129878
[TBL] [Abstract][Full Text] [Related]
24. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
Prescrire Int; 2005 Aug; 14(78):127-32. PubMed ID: 16106594
[TBL] [Abstract][Full Text] [Related]
25. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
26. Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.
Kovacs MJ; Kearon C; Rodger M; Anderson DR; Turpie AG; Bates SM; Desjardins L; Douketis J; Kahn SR; Solymoss S; Wells PS
Circulation; 2004 Sep; 110(12):1658-63. PubMed ID: 15364803
[TBL] [Abstract][Full Text] [Related]
27. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program.
Bridges GG; Lee MD; Jenkins JK; Stephens MA; Croce MA; Fabian TC
J Trauma; 2003 Feb; 54(2):232-5. PubMed ID: 12579045
[TBL] [Abstract][Full Text] [Related]
28. Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.
Nutescu EA; Wittkowsky AK; Dobesh PP; Hawkins DW; Dager WE
Ann Pharmacother; 2006 Sep; 40(9):1558-71. PubMed ID: 16912250
[TBL] [Abstract][Full Text] [Related]
29. Thromboembolism in atrial fibrillation.
Menke J; Lüthje L; Kastrup A; Larsen J
Am J Cardiol; 2010 Feb; 105(4):502-10. PubMed ID: 20152245
[TBL] [Abstract][Full Text] [Related]
30. Early antithrombotic therapy for aortic valve bioprostheses: is there an indication for routine use?
Jamieson WR; Moffatt-Bruce SD; Skarsgard P; Hadi MA; Ye J; Fradet GJ; Abel JG; Janusz MT; Cheung A; Germann E
Ann Thorac Surg; 2007 Feb; 83(2):549-56; discussion 556-7. PubMed ID: 17257986
[TBL] [Abstract][Full Text] [Related]
31. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation.
Waldo AL; Becker RC; Tapson VF; Colgan KJ;
J Am Coll Cardiol; 2005 Nov; 46(9):1729-36. PubMed ID: 16256877
[TBL] [Abstract][Full Text] [Related]
32. [Thromboembolic prophylaxis in hospitalized medical patients].
Braekkan S; Grimsgaard S; Hansen JB
Tidsskr Nor Laegeforen; 2007 May; 127(9):1177-80. PubMed ID: 17479133
[TBL] [Abstract][Full Text] [Related]
33. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
34. Effect and outcomes of the ASGE guidelines on the periendoscopic management of patients who take anticoagulants.
Gerson LB; Gage BF; Owens DK; Triadafilopoulos G
Am J Gastroenterol; 2000 Jul; 95(7):1717-24. PubMed ID: 10925974
[TBL] [Abstract][Full Text] [Related]
35. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
36. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
[TBL] [Abstract][Full Text] [Related]
38. Patterns of use of antithrombotic therapy and quality of anticoagulation among patients with non-valvular atrial fibrillation in clinical practice.
Boulanger L; Kim J; Friedman M; Hauch O; Foster T; Menzin J
Int J Clin Pract; 2006 Mar; 60(3):258-64. PubMed ID: 16494639
[TBL] [Abstract][Full Text] [Related]
39. Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation.
Flaker GC; McGowan DJ; Boechler M; Fortune G; Gage B
Am Heart J; 1999 Feb; 137(2):307-12. PubMed ID: 9924165
[TBL] [Abstract][Full Text] [Related]
40. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry.
Wang TY; Robinson LA; Ou FS; Roe MT; Ohman EM; Gibler WB; Smith SC; Peterson ED; Becker RC
Am Heart J; 2008 Feb; 155(2):361-8. PubMed ID: 18215609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
